| RS2531795490 |
ERCC8
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2531795499 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS2531795527 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2531795554 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS2531798342 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS2531798348 |
ERCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2531798461 |
ERCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS2531802219 |
ERCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
UV-sensitive syndrome 2, Cockayne syndrome type 1 |
| RS2531802244 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS2531802402 |
ERCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS2531803201 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2531805137 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2531807956 |
SPINK5
|
Health Risk |
Pathogenic |
Ichthyosis linearis circumflexa, Ichthyosis linearis circumflexa |
| RS2531825719 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS2531826011 |
NR3C2
|
Health Risk |
Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS2531829170 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS2531829191 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2531832380 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531835861 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS2531839298 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531839441 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS2531839542 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2531840596 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531840868 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531841080 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531841219 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531841267 |
HSD17B4
|
Health Risk |
Pathogenic |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS2531841327 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2531842297 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531842449 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2531852584 |
ERCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2531852602 |
ERCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2531857217 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Febrile seizures, familial |
| RS2531865376 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS2531868360 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531880879 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2531884877 |
TAPT1
|
Health Risk |
Likely pathogenic |
— |
| RS2531892073 |
NDUFAF2
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2531892396 |
NDUFAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 10 |
| RS2531899300 |
ADGRV1
|
Health Risk |
Likely pathogenic |
ADGRV1-related disorder, ADGRV1-related disorder |
| RS2531901971 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2531902012 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531903536 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2531904772 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2531905463 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2531911970 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531912062 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Perrault syndrome 1, Perrault syndrome 1 |
| RS2531912089 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531912467 |
HSD17B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2531912482 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531912705 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531912732 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531921839 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531922377 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531922658 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531927990 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2531935679 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531935860 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2531936875 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531938775 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531938791 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2531939450 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2531939747 |
ADGRV1
|
Health Risk |
Likely pathogenic |
ADGRV1-related disorder, ADGRV1-related disorder |
| RS2531940231 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2531940831 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2531942525 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531942664 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531952888 |
CACNA1C
|
Health Risk |
Pathogenic |
— |
| RS2531953881 |
HSD17B4
|
Health Risk |
Pathogenic |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS2531954780 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531954907 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2531979897 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531981299 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531982021 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531982920 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531983477 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531983634 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531983649 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531989713 |
PDE8B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2531999348 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2531999906 |
ADGRV1
|
Health Risk |
Pathogenic |
Monogenic hearing loss, Monogenic hearing loss |
| RS2532001058 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2532008000 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532009048 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532012725 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532013049 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532013251 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532013279 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532013596 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2532025300 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS2532029941 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532030559 |
NDUFAF2
|
Health Risk |
Likely pathogenic |
— |
| RS2532030623 |
NDUFAF2
|
Health Risk |
Pathogenic |
— |
| RS2532030738 |
NDUFAF2
|
Health Risk |
Pathogenic |
— |
| RS2532030864 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2532032921 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2532040581 |
CAMK4
|
Health Risk |
Pathogenic |
— |
| RS2532073497 |
TRIO
|
Health Risk |
Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS2532074787 |
DDX41
|
Health Risk |
Pathogenic |
DDX41-related hematologic malignancy predisposition syndrome, DDX41-related hematologic malignancy predisposition syndrome |
| RS2532075001 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |